Eye radiation dose from breast cancer screening using full field digital mammography and digital breast tomosynthesis: A phantom study

• Published in: Radiography (London, England. 1995) England. 1995), 2024-01, Vol.30 (1), p.141-144
• Main Authors: M.Ali, R.M.K., Hogg, P.
• Format: Article
• Language: English
• Subjects: Breast Neoplasms - diagnostic imaging; Dosimetry; Early Detection of Cancer; Eye radiosensitivity; Female; Humans; Mammography; Radiation Dosage; Radiation hazard; Radiographic Image Enhancement; Thermoluminescent dosimeters
• ISSN: 1078-8174; 1532-2831; 1532-2831
• DOI: 10.1016/j.radi.2023.10.021

The eye lens is recently classified as one of the most radiosensitive tissues by the International Commission on Radiological Protection (ICRP), and it has been suggested that the eye lens receives radiation dose during mammography due to scatter radiation. The aim of this study was to investigate the radiation dose received by the lens of the clients’ eye from Full Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) screening. The eye radiation dose received by ATOM dosimetry phantom was estimated with thermo-luminescent dosemeters (TLDs). One TLD was utilised for each eye. A breast phantom was exposed for four-view screening mammography using 16 FFDM machines and one DBT machine. The breast phantom was exposed three times for each mammographic position and an average TLD dose reading was considered to minimise random error. For four-view FFDM screening, the phantom eye radiation dose ranges from 0.013 mGy to 0.029 mGy with a mean±sd of 0.019 ± 0.005 mGy. A higher eye radiation dose of 0.041 mGy was recorded from four-view DBT screening. The statistical analysis demonstrated that the eye lens radiation dose is strongly and significantly correlated to breast organ dose and X-ray tube voltage. The phantom eye lens was exposed to scatter radiation from FFDM and DBT screening. The measured dose via the four-view DBT screening was higher than the four-view FFDM screening, but sits below the internationally acceptable ranges. If the findings of our paper hold true in practice, then the risk to the lens of the eyes for women attending breast screening is acceptable. The new lens radiation dose levels recommended by the ICRP necessitate the reevaluation of eye radiation dose from different radiographic examinations, especially those used for screening purpose where healthy individuals involved.